Copyright
©The Author(s) 2019.
World J Meta-Anal. May 31, 2019; 7(5): 209-217
Published online May 31, 2019. doi: 10.13105/wjma.v7.i5.209
Published online May 31, 2019. doi: 10.13105/wjma.v7.i5.209
Figure 1 Treatment algorithm for HBsAg negative, anti-HBc positive patients undergoing immunosuppression.
Future research may help determine whether HBcrAg has a role in determining whether patients with HBsAg negative with anti-HBc positive with undetectable DNA undergo HBV chemoprophylaxis or “on-demand” treatment. HBV: Hepatitis B virus.
- Citation: Wu CCH, Kumar R. Hepatitis B reactivation in patients with hepatitis B core antibody positive and surface antigen negative on immunosuppressants. World J Meta-Anal 2019; 7(5): 209-217
- URL: https://www.wjgnet.com/2308-3840/full/v7/i5/209.htm
- DOI: https://dx.doi.org/10.13105/wjma.v7.i5.209